Latest Biotech News

University of Geneva researchers identified two key proteins involved in the chromatin remodeling process that regulates gene accessibility, which is crucial for controlled gene expression....

Revolution Medicines finalized a major financing agreement with Royalty Pharma, obtaining up to $2 billion in committed capital to support late-stage development and commercialization of its...

Researchers at Virginia Commonwealth University’s Massey Cancer Center and the Institute of Molecular Medicine designed a fusion superkine molecule combining interleukin-24S with interleukin-15,...

Revolution Medicines has signed a landmark $2 billion royalty and debt financing deal with Royalty Pharma to support its RAS(ON) inhibitors, including the leading candidate daraxonrasib. This...

The FDA has expanded AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Datroway to include treatment for locally advanced or metastatic epidermal growth factor receptor mutated non-small...

Cidara Therapeutics announced positive Phase IIb trial results for its long-acting antiviral biologic CD-388, demonstrating substantial prevention efficacy against seasonal influenza in healthy,...

Nuvalent has revealed compelling phase 1/2 clinical results for its ROS1 inhibitor zidesamtinib, targeting ROS1-positive non-small cell lung cancer patients who failed prior therapies. The drug...

Illumina has entered into a definitive agreement to acquire proteomics leader SomaLogic from Standard BioTools for up to $425 million, strengthening its multiomics strategy. The purchase includes...

Novo Nordisk has terminated a marketing partnership with telehealth company Hims & Hers Health after only eight weeks, alleging unlawful mass distribution of compounded versions of the obesity...

A multinational research collaboration led by the Garvan Institute has introduced AAnet, an AI-based neural network designed to analyze single-cell gene expression profiles from tumors, revealing...

The UK government has introduced a Modern Industrial Strategy focusing on boosting the life sciences sector to rank as Europe’s leader by 2030 and among the top three globally by 2035. Key...

A collaborative study led by the Spanish National Cancer Research Centre and the University of Cambridge has developed genomic biomarkers based on chromosomal instability (CIN) signatures to...

Nektar Therapeutics reported encouraging Phase 2b data for rezpegaldesleukin (rezpeg), an immune-modulating agent showing statistically significant improvement in skin clearance for patients with...

Cidara Therapeutics reported positive top-line Phase 2b results for its long-acting antiviral biologic CD-388, demonstrating significant efficacy in preventing seasonal influenza in healthy,...

The U.S. Food and Drug Administration is experiencing significant leadership upheaval, highlighted by the announced retirement of Jacqueline Corrigan-Curay, acting head of the Center for Drug...

Illumina has agreed to acquire SomaLogic from Standard BioTools in a deal worth up to $425 million, aiming to bolster its multiomics strategy and proteomics capabilities. This acquisition...

Several innovative cancer therapies and strategic partnerships emerged as focal developments. Roche reported promising Phase 3 trial results combining bispecific and antibody-drug conjugate...

Noteworthy advances in diabetes and obesity therapies include Amgen’s adjustment of dosing schedules for its obesity drug MariTide following Phase 2 data showing significant weight loss but high...

Researchers at the Spanish National Cancer Research Centre and collaborators developed genomic tests harnessing chromosomal instability (CIN) signatures to predict patient resistance to multiple...

Innovations in molecular imaging have emerged with development of novel PET tracers enhancing cancer diagnosis. Shandong Cancer Hospital introduced a peptide-based tracer outperforming ^18F-FDG in...